US6383814B1
(en)
|
1994-12-09 |
2002-05-07 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
US5948767A
(en)
*
|
1994-12-09 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphile/DNA complexes
|
US5939401A
(en)
*
|
1994-12-09 |
1999-08-17 |
Genzyme Corporation |
Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
|
US6331524B1
(en)
|
1994-12-09 |
2001-12-18 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
WO1996041606A2
(en)
*
|
1995-06-08 |
1996-12-27 |
Therexsys Limited |
Improved pharmaceutical compositions for gene therapy
|
FR2741066B1
(fr)
|
1995-11-14 |
1997-12-12 |
Rhone Poulenc Rorer Sa |
Nouveaux agents de transfection et leurs applications pharmaceutiques
|
FR2756491B1
(fr)
*
|
1996-11-29 |
1999-01-08 |
Rhone Poulenc Rorer Sa |
Composition transfectante utile en therapie genique associan t a un virus recombinant incorporant un acide nucleique exog ene, un agent de transfection non viral et non plasmidique
|
FR2750704B1
(fr)
|
1996-07-04 |
1998-09-25 |
Rhone Poulenc Rorer Sa |
Procede de production d'adn therapeutique
|
CN1181422A
(zh)
*
|
1996-10-31 |
1998-05-13 |
上海市肿瘤研究所 |
与生长因子受体结合的多肽所构建的基因转移载体
|
US7008776B1
(en)
|
1996-12-06 |
2006-03-07 |
Aventis Pharmaceuticals Inc. |
Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
|
CN100497610C
(zh)
|
1996-12-06 |
2009-06-10 |
阿温蒂斯药物公司 |
人脂酶样基因编码的多肽及利用它的组合物和方法
|
US6884430B1
(en)
|
1997-02-10 |
2005-04-26 |
Aventis Pharma S.A. |
Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
|
HUP0002922A3
(en)
|
1997-04-28 |
2003-03-28 |
Aventis Pharma Sa |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
FR2763943B1
(fr)
*
|
1997-05-28 |
1999-07-09 |
Rhone Poulenc Rorer Sa |
Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
|
US6875606B1
(en)
|
1997-10-23 |
2005-04-05 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Human α-7 nicotinic receptor promoter
|
WO1999038821A2
(fr)
|
1998-01-30 |
1999-08-05 |
Aventis Pharma S.A. |
Composes transfectants sensibles aux conditions reductrices, compositions pharmaceutiques les contenant, et leurs applications
|
FR2774394B1
(fr)
*
|
1998-01-30 |
2002-04-26 |
Rhone Poulenc Rorer Sa |
Composes transfectants sensibles aux conditions reductrices, compositions pharmaceutiques les contenant, et leurs applications
|
US6225456B1
(en)
|
1998-05-07 |
2001-05-01 |
University Technololy Corporation |
Ras suppressor SUR-5
|
US6506889B1
(en)
|
1998-05-19 |
2003-01-14 |
University Technology Corporation |
Ras suppressor SUR-8 and related compositions and methods
|
FR2786700B1
(fr)
*
|
1998-12-03 |
2002-12-06 |
Aventis Pharma Sa |
Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations
|
WO2000032803A2
(fr)
*
|
1998-12-03 |
2000-06-08 |
Aventis Pharma S.A. |
Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations
|
US6441156B1
(en)
*
|
1998-12-30 |
2002-08-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Calcium channel compositions and methods of use thereof
|
JP4799736B2
(ja)
*
|
1999-02-22 |
2011-10-26 |
ジョージタウン・ユニバーシティ |
全身性遺伝子送達のための抗体フラグメント標的化イムノリポソーム
|
US7780882B2
(en)
*
|
1999-02-22 |
2010-08-24 |
Georgetown University |
Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
|
US9034329B2
(en)
*
|
1999-02-22 |
2015-05-19 |
Georgetown University |
Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
|
GB9918670D0
(en)
|
1999-08-06 |
1999-10-13 |
Celltech Therapeutics Ltd |
Biological product
|
EP1083232B1
(en)
*
|
1999-09-09 |
2005-02-23 |
CureVac GmbH |
Transfer of mRNA using polycationic compounds
|
CA2390716A1
(en)
*
|
1999-09-24 |
2001-04-05 |
Alan D. King |
Process for enhancing electric field-mediated delivery of biological materials into cells
|
CA2402530C
(en)
|
2000-03-13 |
2014-01-14 |
Cornell Research Foundation, Inc. |
Blocking leukocyte emigration and inflammation by interfering with cd99
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
US20030212022A1
(en)
*
|
2001-03-23 |
2003-11-13 |
Jean-Marie Vogel |
Compositions and methods for gene therapy
|
GB0018307D0
(en)
|
2000-07-26 |
2000-09-13 |
Aventis Pharm Prod Inc |
Polypeptides
|
IL151909A0
(en)
*
|
2000-04-12 |
2003-04-10 |
Implyx Ltd |
Peptide conjugates for drug delivery
|
AU5345901A
(en)
|
2000-04-13 |
2001-10-30 |
Univ Rockefeller |
Enhancement of antibody-mediated immune responses
|
US20040142474A1
(en)
*
|
2000-09-14 |
2004-07-22 |
Expression Genetics, Inc. |
Novel cationic lipopolymer as a biocompatible gene delivery agent
|
US6696038B1
(en)
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
FR2814370B1
(fr)
*
|
2000-09-22 |
2004-08-20 |
Centre Nat Rech Scient |
Utilisation d'un complexe acide nucleique/pei pour le ciblage de cellules souches du cerveau
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
US7060442B2
(en)
|
2000-10-30 |
2006-06-13 |
Regents Of The University Of Michigan |
Modulators on Nod2 signaling
|
CN100422210C
(zh)
|
2000-12-28 |
2008-10-01 |
Wyeth公司 |
来自肺炎链球菌的重组防护蛋白质
|
US20030125239A1
(en)
*
|
2001-02-02 |
2003-07-03 |
Andrea Crisanti |
Compositions for drug delivery
|
WO2002063026A1
(en)
*
|
2001-02-08 |
2002-08-15 |
Geneporter, Inc. |
Complexes and components thereof for introducing polynucleotides into eukaryotic cells
|
PT1456346E
(pt)
|
2001-02-20 |
2012-05-02 |
Intrexon Corp |
Novo sistema de expressão de genes induzido baseado no recetor de ecdisona / recetor x retinoide invertebrado
|
JP4994563B2
(ja)
|
2001-02-20 |
2012-08-08 |
イントレキソン コーポレーション |
新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
|
DK1572862T3
(da)
|
2001-02-20 |
2012-11-26 |
Intrexon Corp |
Kimære, retinoide x-receptorer og deres anvendelse i et hidtil ukendt ecdysonrecepttorbaseret inducerbart genekspressionssystem
|
CA2445796C
(en)
|
2001-02-20 |
2014-09-16 |
Rheogene, Inc. |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
EP1499349B1
(en)
|
2001-03-02 |
2009-11-18 |
The Rockefeller University |
Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
|
US8216585B2
(en)
*
|
2001-05-25 |
2012-07-10 |
The Trustees Of The University Of Pennsylvania |
Targeted particles and methods of using the same
|
US20040234586A1
(en)
*
|
2001-06-11 |
2004-11-25 |
Sylvain Meloche |
Compositions and methods for enhancing nucleic acid transfer into cells
|
FR2829136B1
(fr)
|
2001-08-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives lipidiques d'aminoglycosides
|
CA2459827C
(en)
|
2001-09-26 |
2013-09-03 |
Subba Reddy Palli |
Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
|
US7919269B2
(en)
|
2001-09-26 |
2011-04-05 |
Intrexon Corporation |
Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
|
US20040023910A1
(en)
*
|
2001-09-28 |
2004-02-05 |
Zhiming Zhang |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
EP1479985B1
(en)
|
2002-01-17 |
2017-06-14 |
Alfa Laval Corporate AB |
Submerged evaporator comprising a plate heat exchanger and a cylindric casing where the plate heat exchanger is arranged
|
US7037520B2
(en)
*
|
2002-03-22 |
2006-05-02 |
Baylor College Of Medicine |
Reversible masking of liposomal complexes for targeted delivery
|
US7375093B2
(en)
|
2002-07-05 |
2008-05-20 |
Intrexon Corporation |
Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
EP1545593A1
(en)
|
2002-09-27 |
2005-06-29 |
PowderJect Research Limited |
Nucleic acid coated particles
|
JP2006517790A
(ja)
*
|
2003-01-09 |
2006-08-03 |
インヴィトロジェン コーポレーション |
ポリペプチド−核酸複合体の細胞の送達および活性化
|
US7304161B2
(en)
|
2003-02-10 |
2007-12-04 |
Intrexon Corporation |
Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
|
US7456315B2
(en)
|
2003-02-28 |
2008-11-25 |
Intrexon Corporation |
Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
US20070065409A1
(en)
*
|
2003-07-15 |
2007-03-22 |
Behrooz Sharifi |
Use of pleiotrophin in the diagnosis, treatment and prevention of disease
|
US8507277B2
(en)
|
2003-10-24 |
2013-08-13 |
Gencia Corporation |
Nonviral vectors for delivering polynucleotides
|
US20090208478A1
(en)
*
|
2003-10-24 |
2009-08-20 |
Gencia Corporation |
Transducible polypeptides for modifying metabolism
|
CA2543257C
(en)
|
2003-10-24 |
2013-12-31 |
Gencia Corporation |
Methods and compositions for delivering polynucleotides
|
US8062891B2
(en)
|
2003-10-24 |
2011-11-22 |
Gencia Corporation |
Nonviral vectors for delivering polynucleotides to plants
|
US8133733B2
(en)
|
2003-10-24 |
2012-03-13 |
Gencia Corporation |
Nonviral vectors for delivering polynucleotides to target tissues
|
US20090123468A1
(en)
|
2003-10-24 |
2009-05-14 |
Gencia Corporation |
Transducible polypeptides for modifying metabolism
|
US7432057B2
(en)
|
2004-01-30 |
2008-10-07 |
Michigan State University |
Genetic test for PSE-susceptible turkeys
|
EP2270513A3
(en)
|
2004-04-20 |
2011-04-06 |
Galapagos N.V. |
Methods, compositions and compound assays for inhibiting amyloid-beta protein production
|
EP1747462A2
(en)
|
2004-04-27 |
2007-01-31 |
Galapagos N.V. |
Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
EP2270160A1
(en)
|
2004-06-14 |
2011-01-05 |
Galapagos N.V. |
Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases
|
WO2006002161A2
(en)
|
2004-06-18 |
2006-01-05 |
Duke University |
Modulators of odorant receptors
|
US20070004658A1
(en)
|
2004-06-21 |
2007-01-04 |
Nick Vandeghinste |
Method and means for treatment of osteoarthritis
|
US7604798B2
(en)
|
2004-07-15 |
2009-10-20 |
Northwestern University |
Methods and compositions for importing nucleic acids into cell nuclei
|
WO2006020071A2
(en)
|
2004-07-16 |
2006-02-23 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Vaccines against aids comprising cmv/r-nucleic acid constructs
|
US7485468B2
(en)
|
2004-10-15 |
2009-02-03 |
Galapagos Bv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
|
US7964571B2
(en)
|
2004-12-09 |
2011-06-21 |
Egen, Inc. |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
|
US9034650B2
(en)
|
2005-02-02 |
2015-05-19 |
Intrexon Corporation |
Site-specific serine recombinases and methods of their use
|
AU2006259415B2
(en)
*
|
2005-06-15 |
2012-08-30 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
US8088382B2
(en)
|
2005-07-05 |
2012-01-03 |
Cornell Research Foundation, Inc. |
Methods of inhibiting transendothelial migration of neutrophils and monocytes with anti-CD99L2 antibodies
|
US7666584B2
(en)
|
2005-09-01 |
2010-02-23 |
Philadelphia Health & Education Coporation |
Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
|
KR20140135267A
(ko)
*
|
2006-05-15 |
2014-11-25 |
조지타운 유니버시티 |
치료제 또는 진단제의 전신 투여를 위한 항체- 또는 항체 단편-표적화 면역리포좀 제제 및 그의 용도
|
KR100857389B1
(ko)
|
2006-06-30 |
2008-09-11 |
(주)아모레퍼시픽 |
Ap-grr 펩티드 또는 ap-grr 펩티드를 포함하는펩티드사슬 및 이를 포함하는 약물전달담체
|
MX2009000976A
(es)
|
2006-07-28 |
2009-03-09 |
Sanofi Aventis |
Composicion y metodo para el tratamiento de tumores.
|
JP5407862B2
(ja)
*
|
2006-10-04 |
2014-02-05 |
サントル・ナシオナル・ドゥ・ラ・ルシェルシュ・シアンティフィーク(セーエヌエールエス) |
siRNAおよび脂質性4,5−二置換2−デオキシストレプタミン環アミノグリコシド誘導体を含む組成物ならびにその用途
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
US8298781B2
(en)
|
2007-05-08 |
2012-10-30 |
Duke University |
Compositions and methods for characterizing and regulating olfactory sensation
|
MX2009012834A
(es)
|
2007-05-29 |
2010-05-17 |
Intrexon Corp |
Ligandos quirales de diacilhidrazina para modular la expresion de genes exogenos por medio de un complejo receptor de ecdisona.
|
EP2162747B1
(en)
|
2007-06-20 |
2014-04-30 |
Galapagos N.V. |
Molecular targets and methods to identify compounds for treating bone and joint degenerative diseases
|
US20090069266A1
(en)
|
2007-06-27 |
2009-03-12 |
Northwestern University |
Methods and compositions for nucleic acid transfer into cells
|
EP2175835B1
(en)
*
|
2007-07-09 |
2016-04-20 |
Georgetown University |
Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery
|
US9144546B2
(en)
|
2007-08-06 |
2015-09-29 |
Clsn Laboratories, Inc. |
Nucleic acid-lipopolymer compositions
|
EP2185730A4
(en)
|
2007-08-23 |
2010-10-27 |
Intrexon Corp |
METHOD AND COMPOSITIONS FOR SICKNESS DIAGNOSIS
|
KR20100065190A
(ko)
*
|
2007-09-14 |
2010-06-15 |
닛토덴코 가부시키가이샤 |
약물 담체
|
KR20100068435A
(ko)
*
|
2007-09-17 |
2010-06-23 |
롬 앤드 하아스 컴패니 |
식물의 생리적 반응을 변형시키기 위한 조성물 및 방법
|
NZ584848A
(en)
|
2007-09-28 |
2012-09-28 |
Intrexon Corp |
Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
|
EP2042193A1
(en)
|
2007-09-28 |
2009-04-01 |
Biomay AG |
RNA Vaccines
|
US20090123441A1
(en)
|
2007-10-08 |
2009-05-14 |
Intrexon Corporation |
Engineered Dendritic Cells and Uses for the Treatment of Cancer
|
FR2928373B1
(fr)
|
2008-03-05 |
2010-12-31 |
Centre Nat Rech Scient |
Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
|
CA2736425A1
(en)
|
2008-09-11 |
2010-03-18 |
Galapagos Nv |
Method for identifying compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
|
KR20110081282A
(ko)
|
2008-11-05 |
2011-07-13 |
와이어쓰 엘엘씨 |
베타―용혈성 연쇄구균 (bhs) 질환의 예방을 위한 다성분 면역원성 조성물
|
KR101734955B1
(ko)
|
2008-11-07 |
2017-05-12 |
메사추세츠 인스티튜트 오브 테크놀로지 |
아미노알콜 리피도이드 및 그의 용도
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
JP2012518181A
(ja)
|
2009-02-19 |
2012-08-09 |
ガラパゴス・ナムローゼ・フェンノートシャップ |
炎症を包含する疾患の診断及び治療に有用な同定方法及び化合物
|
EP2398479A2
(en)
|
2009-02-19 |
2011-12-28 |
Galapagos N.V. |
Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
|
EP2398481A2
(en)
|
2009-02-19 |
2011-12-28 |
Galapagos N.V. |
Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
|
WO2010112569A1
(en)
|
2009-03-31 |
2010-10-07 |
Robert Zimmermann |
Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor
|
EP2414830A2
(en)
|
2009-03-31 |
2012-02-08 |
Robert Zimmermann |
Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor
|
WO2010115841A1
(en)
|
2009-04-01 |
2010-10-14 |
Galapagos Nv |
Methods and means for treatment of osteoarthritis
|
JP5822822B2
(ja)
|
2009-04-17 |
2015-11-24 |
ニューヨーク ユニバーシティ |
Tnfファミリー受容体を標的とし、tnf作用を拮抗するペプチド、その組成物、方法および使用
|
WO2011015573A1
(en)
|
2009-08-03 |
2011-02-10 |
Galapagos Nv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases
|
WO2011015572A1
(en)
|
2009-08-03 |
2011-02-10 |
Galapagos Nv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases
|
US9186370B2
(en)
|
2010-03-19 |
2015-11-17 |
University Of South Alabama |
Methods and compositions for the treatment of cancer
|
KR102049161B1
(ko)
|
2010-03-23 |
2019-11-26 |
인트렉손 코포레이션 |
치료적 단백질을 조건부로 발현하는 벡터,상기 벡터를 포함하는 숙주 세포 및 이의 용도
|
CA2808975C
(en)
|
2010-08-23 |
2018-10-30 |
Wyeth Llc |
Stable formulations of neisseria meningitidis rlp2086 antigens
|
JP5976652B2
(ja)
|
2010-09-10 |
2016-08-24 |
ワイス・エルエルシー |
髄膜炎菌orf2086抗原の非脂質化変異体
|
EP2649178B8
(en)
|
2010-12-09 |
2017-08-30 |
Institut Pasteur |
Mgmt-based method for obtaining high yield of recombinant protein expression
|
EP2492279A1
(en)
|
2011-02-25 |
2012-08-29 |
Laboratorios Del. Dr. Esteve, S.A. |
Rapid immunogen selection method using lentiviral display
|
JP6189754B2
(ja)
|
2011-03-04 |
2017-08-30 |
イントレキソン コーポレーション |
タンパク質を条件的に発現するベクター
|
WO2012135025A2
(en)
|
2011-03-28 |
2012-10-04 |
Massachusetts Institute Of Technology |
Conjugated lipomers and uses thereof
|
US9458456B2
(en)
|
2011-04-01 |
2016-10-04 |
University Of South Alabama |
Methods and compositions for the diagnosis, classification, and treatment of cancer
|
EP2546358A1
(en)
|
2011-07-15 |
2013-01-16 |
Laboratorios Del. Dr. Esteve, S.A. |
Methods and reagents for efficient control of HIV progression
|
PT2760463T
(pt)
|
2011-09-20 |
2019-02-27 |
Univ North Carolina Chapel Hill |
Regulação de canais de sódio por proteínas plunc
|
WO2013053765A1
(en)
|
2011-10-11 |
2013-04-18 |
Proyecto De Biomedicina Cima, S.L. |
A non-human animal model of mucosa-associated lymphoid tissue (malt) lymphoma
|
JP6151707B2
(ja)
|
2011-10-27 |
2017-06-21 |
マサチューセッツ インスティテュート オブ テクノロジー |
薬物内包微小球の形成が可能なn−末端で官能基化されたアミノ酸誘導体
|
EP2788478B1
(en)
|
2011-12-09 |
2017-08-23 |
Institut Pasteur |
Multiplex immuno screening assay
|
WO2013103401A1
(en)
|
2012-01-06 |
2013-07-11 |
University Of South Alabama |
Methods and compositions for the treatment of cancer
|
CN104334187B
(zh)
|
2012-03-09 |
2017-04-05 |
辉瑞公司 |
脑膜炎双球菌组合物及其方法
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
EP2698377A1
(en)
|
2012-08-17 |
2014-02-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Enhanced rapid immunogen selection method for HIV gp120 variants
|
JP6446377B2
(ja)
|
2013-03-08 |
2018-12-26 |
ファイザー・インク |
免疫原性融合ポリペプチド
|
WO2014139885A2
(en)
|
2013-03-14 |
2014-09-18 |
Galapagos Nv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of diseases associated with epithelial mesenchymal transition
|
US9952202B2
(en)
|
2013-03-14 |
2018-04-24 |
Galapagos Nv |
Methods of identifying compounds for the treatment of fibrosis by using S1PR5
|
EP2972322B1
(en)
|
2013-03-14 |
2019-03-06 |
Galapagos NV |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrotic diseases
|
AU2014227571B2
(en)
|
2013-03-15 |
2017-02-02 |
Intrexon Corporation |
Boron-containing diacylhydrazines
|
US20160130585A1
(en)
|
2013-05-28 |
2016-05-12 |
The Johns Hopkins University |
Aptamers for the treatment of sickle cell disease
|
WO2015033251A2
(en)
|
2013-09-08 |
2015-03-12 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
KR101605421B1
(ko)
|
2014-03-05 |
2016-03-23 |
국립암센터 |
B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
|
WO2016004202A1
(en)
|
2014-07-02 |
2016-01-07 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
TW201625650A
(zh)
|
2014-09-17 |
2016-07-16 |
英翠克頌公司 |
含硼之二醯基肼化合物
|
US10308705B2
(en)
|
2015-02-06 |
2019-06-04 |
The University Of North Carolina At Chapel Hill |
Optimized human clotting factor VIII gene expression cassettes and their use
|
CN107249626A
(zh)
|
2015-02-19 |
2017-10-13 |
辉瑞大药厂 |
脑膜炎奈瑟球菌组合物及其方法
|
TW201710503A
(zh)
|
2015-06-12 |
2017-03-16 |
長庚醫療財團法人林口長庚紀念醫院 |
新穎多核苷酸、載體、醫藥組成物以及其用途
|
AU2016278970B2
(en)
|
2015-06-19 |
2020-10-29 |
Massachusetts Institute Of Technology |
Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
|
AU2016328279A1
(en)
|
2015-09-24 |
2018-05-10 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for reducing metastases
|
EP3347373A1
(en)
|
2015-10-10 |
2018-07-18 |
Intrexon Corporation |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
AU2017222450A1
(en)
|
2016-02-22 |
2018-09-27 |
The University Of North Carolina At Chapel Hill |
Peptide inhibitors of calcium channels
|
BR112019009446A2
(pt)
|
2016-11-09 |
2019-07-30 |
Intrexon Corp |
construtos de expressão da frataxina
|
WO2018096457A1
(en)
|
2016-11-22 |
2018-05-31 |
Kabushiki Kaisha Toshiba |
Nucleic acid condensing peptide, nucleic acid condensing peptide set, nucleic acid delivery carrier, nucleic acid delivery method, cell production method, cell detection method and kit
|
KR102567845B1
(ko)
|
2017-01-31 |
2023-08-17 |
화이자 인코포레이티드 |
네이세리아 메닌기티디스 조성물 및 그의 방법
|
US20200393446A1
(en)
|
2017-12-08 |
2020-12-17 |
Centre National De La Recherche Scientifique (Cnrs) |
Bioluminescent screening test for detecting cell cytolysis
|
EP3539975A1
(en)
|
2018-03-15 |
2019-09-18 |
Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron |
Micropeptides and uses thereof
|
CA3109209A1
(en)
|
2018-08-10 |
2020-02-13 |
Eutilex Co., Ltd. |
Chimeric antigen receptor that binds hla-dr and car-t cell
|
AU2020236937B2
(en)
|
2019-03-08 |
2023-06-15 |
Obsidian Therapeutics, Inc. |
CD40L compositions and methods for tunable regulation
|
US20210069242A1
(en)
|
2019-04-18 |
2021-03-11 |
Dmitry Dmitrievich Genkin |
Reprogramming of polymorphonuclear leukocytes
|
MX2022008415A
(es)
|
2020-01-08 |
2022-08-08 |
Obsidian Therapeutics Inc |
Composiciones y metodos para la regulacion ajustable de la transcripcion.
|
EP3885440A1
(en)
|
2020-03-26 |
2021-09-29 |
Splicebio, S.L. |
Split inteins and their uses
|
WO2023242436A1
(en)
|
2022-06-17 |
2023-12-21 |
Danmarks Tekniske Universitet |
Allergy vaccines based on consensus allergens
|